Implementation of multimodal computed tomography in a telestroke network: Five-year experience.


Journal

CNS neuroscience & therapeutics
ISSN: 1755-5949
Titre abrégé: CNS Neurosci Ther
Pays: England
ID NLM: 101473265

Informations de publication

Date de publication:
03 2020
Historique:
received: 22 07 2019
revised: 27 08 2019
accepted: 04 09 2019
pubmed: 1 10 2019
medline: 1 7 2021
entrez: 1 10 2019
Statut: ppublish

Résumé

Penumbral selection is best-evidence practice for thrombectomy in the 6-24 hour window. Moreover, it helps to identify the best responders to thrombolysis. Multimodal computed tomography (mCT) at the primary centre-including noncontrast CT, CT perfusion, and CT angiography-may enhance reperfusion therapy decision-making. We developed a network with five spoke primary stroke sites and assessed safety, feasibility, and influence of mCT in rural hospitals on decision-making for thrombolysis. Consecutive patients assessed via telemedicine from April 2013 to June 2018. Clinical outcomes were measured, and decision-making compared using theoretical models for reperfusion therapy applied without mCT guidance. Symptomatic intracranial hemorrhage (sICH) was assessed according to Safe Implementation of Treatments in Stroke Thrombolysis Registry criteria. A total of 334 patients were assessed, 240 received mCT, 58 were thrombolysed (24.2%). The mean age of thrombolysed patients was 70 years, median baseline National Institutes of Health Stroke Scale was 10 (IQR 7-18) and 23 (39.7%) had a large vessel occlusion. 1.7% had sICH and 3.5% parenchymal hematoma. Three months poststroke, 55% were independent, compared with 70% in the non-thrombolysed group. Implementation of CTP in rural centers was feasible and led to high thrombolysis rates with low rates of sICH.

Identifiants

pubmed: 31568661
doi: 10.1111/cns.13224
pmc: PMC7052799
doi:

Types de publication

Journal Article Multicenter Study Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

367-373

Investigateurs

Rachel Peake (R)
James Hughes (J)
Lisa Dark (L)
Nick Ryan (N)
Matt Shepherd (M)
Osama Ali (O)
James Wills (J)
Fiona Minett (F)
Jaclyn Birnie (J)
Amanda Buzio (A)
Iain Bruce (I)
Alan Tankel (A)
Kim Parrey (K)
Matthew Kinchington (M)
Elizabeth Pepper (E)
Andre Loiselle (A)
Sophie Waller (S)
Alvin Chew (A)
Michelle Russell (M)
Angela Royan (A)
Brett Roworth (B)

Informations de copyright

© 2019 The Authors. CNS Neuroscience & Therapeutics Published by John Wiley & Sons Ltd.

Références

Stroke. 2017 Jan;48(1):e3-e25
pubmed: 27811332
N Engl J Med. 2019 May 9;380(19):1795-1803
pubmed: 31067369
N Engl J Med. 2018 Feb 22;378(8):708-718
pubmed: 29364767
Lancet. 2007 Jan 27;369(9558):275-82
pubmed: 17258667
J Emerg Med. 2009 Jan;36(1):12-8
pubmed: 18242925
Lancet Neurol. 2012 Oct;11(10):860-7
pubmed: 22954705
BMC Health Serv Res. 2014 Dec 19;14:643
pubmed: 25523241
Lancet. 2019 Jul 13;394(10193):139-147
pubmed: 31128925
Stroke. 2006 Jul;37(7):1822-7
pubmed: 16763192
Ann Neurol. 2016 Aug;80(2):286-93
pubmed: 27352245
CNS Neurosci Ther. 2020 Mar;26(3):367-373
pubmed: 31568661
Stroke. 2010 Jun;41(6):1251-8
pubmed: 20431081
Stroke. 1999 Feb;30(2):464-9
pubmed: 9933289
Lancet Neurol. 2008 Sep;7(9):787-95
pubmed: 18676180
Stroke. 2016 Jul;47(7):1914-6
pubmed: 27197850
Neurology. 2016 Sep 27;87(13):1344-51
pubmed: 27566746
Stroke. 2004 Jun;35(6):1355-9
pubmed: 15118173
Stroke. 2012 Oct;43(10):2648-53
pubmed: 22858726
Brain. 2015 Jul;138(Pt 7):1919-31
pubmed: 25808369
N Engl J Med. 2018 Jan 4;378(1):11-21
pubmed: 29129157
J Clin Neurosci. 2017 Mar;37:1-5
pubmed: 27887976
Stroke. 2011 Nov;42(11):3291-3
pubmed: 21885843
Stroke. 2018 Mar;49(3):e46-e110
pubmed: 29367334
Radiology. 2013 May;267(2):543-50
pubmed: 23264345
Neurology. 2011 Mar 29;76(13):1145-52
pubmed: 21368283

Auteurs

Carlos Garcia-Esperon (C)

Department of Neurology, John Hunter Hospital, Hunter New England Local Health District, Newcastle, NSW, Australia.
Hunter Medical Research Institute and University of Newcastle, Newcastle, NSW, Australia.

Frode Soderhjelm Dinkelspiel (F)

Karolinska Institutet, Stockholm, Sweden.

Ferdi Miteff (F)

Department of Neurology, John Hunter Hospital, Hunter New England Local Health District, Newcastle, NSW, Australia.
Hunter Medical Research Institute and University of Newcastle, Newcastle, NSW, Australia.

Shyam Gangadharan (S)

Department of Neurology, John Hunter Hospital, Hunter New England Local Health District, Newcastle, NSW, Australia.
Hunter Medical Research Institute and University of Newcastle, Newcastle, NSW, Australia.

Tom Wellings (T)

Department of Neurology, John Hunter Hospital, Hunter New England Local Health District, Newcastle, NSW, Australia.
Hunter Medical Research Institute and University of Newcastle, Newcastle, NSW, Australia.

Bill O Brien (B)

Neurosciences Department, Gosford Hospital, Central Coast Local Health District, Gosford, NSW, Australia.

James Evans (J)

Neurosciences Department, Gosford Hospital, Central Coast Local Health District, Gosford, NSW, Australia.

Tom Lillicrap (T)

Department of Neurology, John Hunter Hospital, Hunter New England Local Health District, Newcastle, NSW, Australia.
Hunter Medical Research Institute and University of Newcastle, Newcastle, NSW, Australia.

Jelle Demeestere (J)

Neurology Department, Leuven University Hospital, Leuven, Belgium.

Andrew Bivard (A)

Department of Neurology, Melbourne Brain Centre at the Royal Melbourne Hospital, University of Melbourne, Parkville, VIC, Australia.

Mark Parsons (M)

Hunter Medical Research Institute and University of Newcastle, Newcastle, NSW, Australia.
Department of Neurology, Melbourne Brain Centre at the Royal Melbourne Hospital, University of Melbourne, Parkville, VIC, Australia.

Neil James Spratt (NJ)

Department of Neurology, John Hunter Hospital, Hunter New England Local Health District, Newcastle, NSW, Australia.
Hunter Medical Research Institute and University of Newcastle, Newcastle, NSW, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH